Designer babies? It’s far from a whimsy, and now a new technology that would make it possible to alter human DNA at the germline (meaning changing traits that can be inherited) has scientists calling for caution and a freeze.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by University of Otago cancer genetics researchers.
A quarter of the dogs taken in by one California animal shelter look like Chihuahuas. So how do you make a pet stand out when it's similar to so many other dogs at the shelter? Check the DNA.
Genetic samples collected from across the United Kingdom are shedding light on the ancient past, including Viking invasions and a mystery about the arrival of the Anglo-Saxons.
Highly sensitive genomic analysis of acute lymphoblastic leukemia cells reveals for the first time how the malignant cells evolve to cause relapse.
The largest genetic study of tuberculosis (TB) susceptibility to date has led to a potentially important new insight into how the pathogen manages to evade the immune system.
Research showed that bleeding events were drastically decreased in animals with hemophilia B. Using a viral vector to swap out faulty genes proved safe and could be used for the more common hemophilia A.
Many animals, including humans, acquired essential ‘foreign’ genes from microorganisms cohabiting their environment in ancient times, according to research published in the open access journal Genome Biology.
A new study reveals an important connection between dozens of genes that may contribute to autism, a major step toward understanding how brain development goes awry in some individuals with the disorder.
In an advance that could lead to better identification of malignant pediatric adrenocortical tumors, and ultimately to better treatment, researchers have mapped the “genomic landscape” of these rare childhood tumors. Their genomic mapping has revealed unprecedented details, not only of the aberrant genetic and chromosomal changes that drive the cancer, but the sequence of those changes that trigger it.
Thyroid hormones have important and diverse roles in human health and regulate metabolic rate. Thyroid disease is common (affecting 5-10 per cent of the population) and synthetic thyroid hormones are one of the commonest drug therapies prescribed worldwide.
A study reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer’s disease produce the disorder’s devastating effects.
A provocative study in mice suggests something as simple as breathing in extra oxygen might give immune cells a boost in attacking cancer.
Beckman Coulter Life Sciences, through a partnership with Illumina, offers automated methods to improve processes and throughput in next generation sequencing (NGS) sample preparation. Under the agreement, Beckman Coulter will use its experience in automated NGS sample preparation to develop, distribute and support automation for Illumina’s TruSeq and Nextera sample preparation kits and Illumina will provide technical expertise on chemistry and protocols.
Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently with greater aggressiveness, is one of the least-understood aspects of the disease.
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Cells provide individualized model for studying obesity and testing treatments.
You might resemble or act more like your mother, but a novel research study from UNC School of Medicine researchers reveals that mammals are genetically more like their dads.
Following the traces of evolution: researches find a key to the reproduction of brain stem cells
Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer’s disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.
Genetically engineered T memory stem cells (Tscm) can last more than 12 years in patients’ bodies, and can continually generate appropriate T cell armies for them, says an innovative study looking at two historic clinical trials.
Researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.
A technique developed by researchers has implications for understanding how cancer cells evolve as a tumor grows or how a virus spreads and changes during an infection.
Findings point to role of natural selection in disease.
The bill granting the controversial techniques was passed Tuesday by the House of Lords, after being approved earlier this month by the House of Commons.